Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)
Agency: National Institutes of Health
- 93.847 -- Diabetes, Digestive, and Kidney Diseases Extramural Research
Closed opportunityLast Updated: Jun 8, 2026
Important dates
- Closed: October 9, 2026
Award details
- Expected project funding: $3,000,000
- Expected awards: 3
Award min.
Not specified
Award max.
$1,000,000
- Funding opportunity number:RFA-DK-27-121
- Cost sharing or matching requirement:No
- Funding instrument type:
- Cooperative agreement
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Health
- Category Explanation:Not specified
History
- Posted date: June 8, 2026
- Archive date: December 8, 2026
- Version: 1
Summary
Jump to documentsEligibility
Nonprofit
- Nonprofits non-higher education without 501(c)(3)
- Nonprofits non-higher education with 501(c)(3)
- Other Native American tribal organizations
Business
- For-profit organizations other than small businesses
- Small businesses
Education
- Private institutions of higher education
- Independent school districts
- Public and state institutions of higher education
Government
- County governments
- Federally recognized Native American tribal governments
- State governments
- Special district governments
- City or township governments
- Public and Indian housing authorities
Miscellaneous
- Other
Additional information on eligibility
Documents
| File name | Description | Last updated |
|---|---|---|
| RFA-DK-27-121-Full-Announcement.html | RFA-DK-27-121-Full-Announcement.html | Jun 8, 2026 06:47 PM UTC |
Agency contact information
Email: voula.osganian@nih.gov
voula.osganian@nih.gov
Link to additional information
No additional information is available
